Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Key facts

Sponsor

Universitätsmedizin Mannheim

Principal Investigator

Frank A. Giordano, MD

Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany

Intervention

Standard surgery(procedure)

Enrollment

314 enrolled

Eligibility

18-80 years · All sexes

Timeline

2016 – 2026

Study locations (19)

• Barrow Neurological Institute (SJHMC), Phoenix, Arizona, United States
• Stritch School of Medicine Loyola University, Maywood, Illinois, United States
• Long Island Jewish Medical Center, North Shore University Hospital, Lake Success, New York, United States
• Lenox Hill Hospital, Hofstra Northwell School of Medicine, New York, New York, United States
• West Virginia University, Morgantown, West Virginia, United States
• Hospital Alemão Oswaldo Cruz, São Paulo, Brazil
• Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada
• Beijing Tian Tan Hospital, Capital Medical University, Beijing, China
• University Hospital Augsburg, Augsburg, Germany
• Charité - Universitätsmedizin, Berlin, Germany
• St. Georg Hospital, Leipzig, Germany
• University Hospital Mannheim, Mannheim, Germany
• Technical University of Munich (TUM), Department of Radiation Oncology, Munich, Germany
• Klinikum Stuttgart, Stuttgart, Germany
• Helios University Hospital Wuppertal, Wuppertal, Germany
• +4 more locations on ClinicalTrials.gov

Collaborators

Carl Zeiss Meditec AG · University of California, Los Angeles

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT06176066
  PH Sensitive MRI Based Resections of Glioblastoma
  University of California, Los Angeles
• RECRUITINGNCT05864976
  Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
  Washington University School of Medicine
• ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05685004
  Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
  TVAX Biomedical
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04922723
  Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
  West Virginia University
• RECRUITINGPHASE1NCT05083754
  Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• ACTIVE NOT RECRUITINGPHASE1NCT04968366
  Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
  Beijing Tiantan Hospital
• ACTIVE NOT RECRUITINGPHASE2NCT04574856
  Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
  University of Michigan Rogel Cancer Center
• ACTIVE NOT RECRUITINGPHASE2NCT04116411
  A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
  Cecilia Soderberg-Naucler

See all trials for Giant cell glioblastoma →